Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension

被引：54
|
作者：
Li, Gang [1 ]
Hu, Rui [2 ]
Zhang, Xuejiao [1 ]
机构：
[1] Hebei Gen Hosp, Geriatr Inst, Cardiol Div, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Gen Clin Lab, Hosp 2, Shijiazhuang, Hebei, Peoples R China
来源：
HYPERTENSION RESEARCH | 2020年 / 43卷 / 06期
基金：
中国国家自然科学基金;
关键词：
ANGIOTENSIN-CONVERTING ENZYME; SARS CORONAVIRUS; ACE2; RECEPTOR; EXPRESSION; PNEUMONIA;
D O I：
10.1038/s41440-020-0433-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：588 / 590
页数：3
相关论文
共 50 条
  • [31] Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
    Zhe Zhang
    Shengyong Wu
    Zhiyong Wang
    Yue Wang
    Hui Chen
    Cheng Wu
    Lize Xiong
    BMC Infectious Diseases, 23
  • [32] Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
    Alrashed, Ahmed A.
    Khan, Tahir M.
    Alhusseini, Noara K.
    Asdaq, Syed Mohammed Basheeruddin
    Enani, Mushira
    Alosaimi, Bandar
    Alkhani, Nada M.
    Mohzari, Yahya
    Alghalbi, Maram M.
    Alfahad, Wafa
    Alanazi, Mona A.
    Albujaidya, Asma S.
    Ben-Akresh, Amal
    Almutairi, Malak
    Abraham, Ivo
    Alamer, Ahmad
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (06) : 726 - 733
  • [33] Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
    Gao, Chao
    Cai, Yue
    Zhang, Kan
    Zhou, Lei
    Zhang, Yao
    Zhang, Xijing
    Li, Qi
    Li, Weiqin
    Yang, Shiming
    Zhao, Xiaoyan
    Zhao, Yuying
    Wang, Hui
    Liu, Yi
    Yin, Zhiyong
    Zhang, Ruining
    Wang, Rutao
    Yang, Ming
    Hui, Chen
    Wijns, William
    McEvoy, J. William
    Soliman, Osama
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Tao, Ling
    Li, Fei
    EUROPEAN HEART JOURNAL, 2020, 41 (22) : 2058 - 2066
  • [34] Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
    Huang, Nancy Xurui
    Yuan, Qi
    Fang, Fang
    Yan, Bryan P.
    Sanderson, John E.
    PLOS ONE, 2023, 18 (01):
  • [35] ACEI和ARB治疗COVID-19合并高血压患者的效果分析
    陈凤
    邹容容
    王君
    广东医学, 2024, 45 (04) : 439 - 446
  • [36] COVID-19 in Patients with Hypertension
    Quinaglia, Thiago
    Shabani, Mahsima
    Rezaei, Nima
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 243 - 261
  • [37] Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
    Bertsimas, Dimitris
    Borenstein, Alison
    Mingardi, Luca
    Nohadani, Omid
    Orfanoudaki, Agni
    Stellato, Bartolomeo
    Wiberg, Holly
    Sarin, Pankaj
    Varelmann, Dirk J.
    Estrada, Vicente
    Macaya, Carlos
    Gil, Ivan J. Nunez
    HEALTH CARE MANAGEMENT SCIENCE, 2021, 24 (02) : 339 - 355
  • [38] Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
    Dimitris Bertsimas
    Alison Borenstein
    Luca Mingardi
    Omid Nohadani
    Agni Orfanoudaki
    Bartolomeo Stellato
    Holly Wiberg
    Pankaj Sarin
    Dirk J. Varelmann
    Vicente Estrada
    Carlos Macaya
    Iván J. Núñez Gil
    Health Care Management Science, 2021, 24 : 339 - 355
  • [39] Reasons for not adapting ongoing antihypertensive treatment in patients with uncontrolled hypertension, treated with an ARB in monotherapy
    Denolle, T.
    Clerson, P.
    Koch, C.
    Fresneau, L.
    Prost, P. -I.
    Pathak, A.
    JOURNAL OF HYPERTENSION, 2008, 26 : S466 - S466
  • [40] ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis
    Zhang, Xue
    Yu, Jiong
    Pan, Li-ya
    Jiang, Hai-yin
    PHARMACOLOGICAL RESEARCH, 2020, 158
12345